HIGHLIGHTS
- who: Petra Loid and collaborators from the Leiden University Medical Center Odense University Hospital, Denmark have published the paper: Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosis, in the Journal: (JOURNAL)
- what: The authors report unaltered lipocalin-2 levels in WNT1 and PLS3 mutation-positive subjects but a strong association with FGF23 concentrations. This study investigated whether lipocalin-2 could be a novel biomarker for WNT1 and PLS3 osteoporosis and explored its relationship to other parameters of bone and mineral metabolism. The study demonstrates that the circulating levels of lipocalin-2 are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.